Clinical trial

SHR9549 in ER Positive HER2 Negative Advanced Breast Cancer

NCT03596658

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2018-07-25

PhasePHASE1

Study timeline

Study start (actual)2018-07-25Date precision: day

Registry last updated2022-09-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

ER+ HER2- Advanced Breast Cancerunresolved

Interventions

SHR9549DRUG

Sponsors & collaborators

Jiangsu HengRui Medicine Co., Ltd.lead sponsor

Mapped research locations

BeijingBeijing Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03596658 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.